Cardiovascular risk assessment by primary-care physicians in Germany and its lack of agreement with the established risk scores (DETECT);Kardiovaskuläre risikoabschätzung in der hausarztpraxis (DETECT): Wie gut stimmt die hausarzteinschätzung mit den etablierten risikoscores überein?

Medizinische Klinik

Volumn 103, Issue 9, 2008, Pages 638-645

  Silber, Sigmund ^a,d   Jarre, Frauke ^b   Pittrow, David ^b   Klotsche, Jens ^b   Pieper, Lars ^b   Zeiher, Andreas Michael ^c   Wittchen, Hans Ulrich ^b  

^a Kardiologische Praxis und Praxisklinik   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Assessment of the primary care physician; Cardiovascular risk; Coronary heart disease; Score

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GERMANY; HEART INFARCTION; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIMARY MEDICAL CARE; RISK ASSESSMENT;

ADULT; AGED; CARDIOVASCULAR DISEASES; CORONARY DISEASE; GERMANY; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIANS, FAMILY; RISK ASSESSMENT; TIME FACTORS;

EID: 52949114893     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-008-1103-2     Document Type: Article

References (27)

1. Schindler C, Siegert J, Kirch W. Physical activity and cardiovascular performance - how important is cardiorespiratory fitness in childhood? J Public Health 2008;16:235-43.
2. Pyorala K, De Backer G, Graham I, et al. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994;15:1300-31.
3. Robson J. Information needed to decide about cardiovascular treatment in primary care. BMJ 1997;314:277-80.
4. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Münster (PROCAM) study. Circulation 2002;105:310-5.
5. Conroy RM, Pyörälä K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
6. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-10.
7. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335:136-48.
8. Keil U, Fitzgerald AP, Gohlke H, et al. Risikoabschätzung tödlicher Herz-Kreislauf-Erkrankungen: die neuen SCORE-Deutschland-Tabellen für die Primärprävention. Dtsch Ärztebl 2005;102:1808-12.
9. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007;14:1-113.
10. Cleeman JI, Grundy SM, Becker D, et al. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
11. Gohlke H, Albus C, Bönner G, et al. Leitlinie der Deutschen Gesellschaft für Kardiologie (DGK): Risikoadjustierte Prävention von Herz- und Kreislauferkrankungen. 2007 (http://www.leitliniendgk.org).
12. Hense H-W, Schulte H, Lowel H, et al. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany - results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003;24:937-45.
13. Thomsen TF, McGee D, Davidsen M, et al. A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 2002;31:817-22.
14. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000;21:365-70.
15. Cullen P, Schulte H, Assmann G. Use of risk factors in determining individual coronary risk. Z Kardiol 2005;94:65-9.
16. Pittrow D, Pieper L, Klotsche J, et al. DETECT Ergebnisse einer klinisch-epidemiologischen Querschnitts- und Verlaufsstudie mit 50.000 Patienten in 3.000 Hausarztpraxen. München: Elsevier, Urban & Fischer, 2007.
17. Wittchen H-U, Glaesmer H, März W, et al. Cardiovascular risk factors in primary care: methods and baseline prevalence rates - the DETECT program. Curr Med Res Opin 2005;21:619-29.
18. Pieper L, Wittchen H-U, Glaesmer H, et al. Kardiovaskuläre Hochrisikokonstellationen in der primärärztlichen Versorgung: DETECT Studie 2003. Bundesgesundheitsblatt 2005;12:1374-82.
19. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-221.
20. Wood D, De Backer G, Faergeman O, et al. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and Other Societies on Coronary Prevention. Eur Heart J 1998;19:1434-503.
21. Greenland P, Lloyd-Jones D. Time to end the mixed - and often incorrect - messages about prevention and treatment of atherosclerotic cardiovascular disease. J Am Coll Cardiol 2007;50:2133-5.
22. Ruof J, Klein G, März W, et al. Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patterns. Prev Med 2002;35:48-53.
23. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65.
24. Pletcher MJ, Tice JA, Pignone M, et al. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med 2004;164:1285-92.
25. Silber S, Richartz B. Evidenzbasierter Einsatz von Kardio-MR und Kardio-CT in der Primärdiagnostik der stabilen koronaren Herzkrankheit unter besonderer Berücksichtigung des Disease-Management-Programms (DMP) KHK und der Nationalen Versorgungsleitlinie. Herz 2007;32:139-58.
26. Diehm C, Lange S, Darius H, et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006;27:1743-9.
27. Sattar N, McConnachie A, Shaper AG, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008;371:1927-35.